Analysts expect that RTI Surgical Inc (NASDAQ:RTIX) will report earnings of $0.02 per share for the current fiscal quarter, according to Zacks. Two analysts have provided estimates for RTI Surgical’s earnings. The firm is expected to announce its next earnings report on Wednesday, July 26th.
On average, analysts expect that RTI Surgical will report full year earnings of $0.06 per share for the current financial year, with EPS estimates ranging from $0.05 to $0.07. For the next year, analysts expect that the company will post earnings of $0.11 per share. Zacks Investment Research’s earnings per share averages are an average based on a survey of research firms that follow RTI Surgical.
RTI Surgical (NASDAQ:RTIX) last announced its quarterly earnings data on Thursday, April 27th. The medical equipment provider reported ($0.05) EPS for the quarter. The firm had revenue of $69.90 million for the quarter, compared to analysts’ expectations of $67.68 million. RTI Surgical had a net margin of 0.24% and a return on equity of 4.60%. The business’s quarterly revenue was up 3.7% compared to the same quarter last year. During the same period in the prior year, the business posted $0.03 EPS.
Separately, Zacks Investment Research downgraded RTI Surgical from a “strong-buy” rating to a “hold” rating in a research report on Thursday, March 2nd.
Shares of RTI Surgical (NASDAQ:RTIX) traded up 1.25% during trading on Thursday, reaching $4.05. The company’s stock had a trading volume of 86,191 shares. RTI Surgical has a one year low of $2.50 and a one year high of $4.35. The company has a 50-day moving average price of $3.87 and a 200-day moving average price of $3.36. The stock’s market cap is $235.16 million.
In related news, Director Jonathon M. Singer acquired 10,000 shares of the company’s stock in a transaction that occurred on Thursday, March 2nd. The shares were bought at an average price of $3.79 per share, with a total value of $37,900.00. Following the completion of the transaction, the director now directly owns 30,270 shares in the company, valued at $114,723.30. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Camille Farhat acquired 83,000 shares of the company’s stock in a transaction that occurred on Friday, February 17th. The shares were bought at an average cost of $3.44 per share, for a total transaction of $285,520.00. The disclosure for this purchase can be found here. 6.10% of the stock is owned by company insiders.
Large investors have recently modified their holdings of the stock. Russell Investments Group Ltd. increased its stake in shares of RTI Surgical by 176.0% in the first quarter. Russell Investments Group Ltd. now owns 78,055 shares of the medical equipment provider’s stock worth $313,000 after buying an additional 49,777 shares during the last quarter. Continental Advisors LLC increased its stake in shares of RTI Surgical by 364.5% in the fourth quarter. Continental Advisors LLC now owns 102,711 shares of the medical equipment provider’s stock worth $334,000 after buying an additional 80,600 shares during the last quarter. SECOR Capital Advisors LP increased its stake in shares of RTI Surgical by 3.4% in the third quarter. SECOR Capital Advisors LP now owns 112,292 shares of the medical equipment provider’s stock worth $351,000 after buying an additional 3,702 shares during the last quarter. Menta Capital LLC increased its stake in shares of RTI Surgical by 84.7% in the fourth quarter. Menta Capital LLC now owns 115,708 shares of the medical equipment provider’s stock worth $376,000 after buying an additional 53,067 shares during the last quarter. Finally, Teachers Advisors LLC increased its stake in shares of RTI Surgical by 32.4% in the fourth quarter. Teachers Advisors LLC now owns 153,071 shares of the medical equipment provider’s stock worth $497,000 after buying an additional 37,436 shares during the last quarter. 77.37% of the stock is currently owned by institutional investors.
About RTI Surgical
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for RTI Surgical Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc and related companies with MarketBeat.com's FREE daily email newsletter.